Used as main image by Phynd in search results and profile page

Michael Edward Woods, MD

Urology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

(888)584-7888
Appointments (New Patients Welcome)
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
(888)584-7888

Services & Specialties

Areas of Specialization

  • Urology

Locations & Contact

Primary Location

Cardinal Bernardin Cancer Center

2160 S First Ave
Maywood , IL 60153

View hours
Monday
12:00am - 12:00am
Tuesday
12:00am - 12:00am
Wednesday
12:00am - 12:00am
Thursday
12:00am - 12:00am
Friday
12:00am - 12:00am
Saturday
12:00am - 12:00am
Sunday
12:00am - 12:00am
Cardinal Bernardin Cancer Center

Saint Joseph Urology

611 E Douglas Rd
Ste 309
Mishawaka , IN 46545-1467

View hours
Monday
8:00am - 4:30pm
Tuesday
8:00am - 4:30pm
Wednesday
8:00am - 4:30pm
Thursday
8:00am - 4:30pm
Friday
8:00am - 12:00pm
Saturday
Sunday

About

Academic Title

Professor

Leadership Title

Medical Director - Cancer Center Clinical Trials Office

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Education

Education:
Loyola University Stritch School of Medicine (2001)

Internship:
Tulane University School of Medicine (2002)

Residency:
Tulane University School of Medicine (2006)

Residency:
Loyola University Medical Center (2006)

Board Certifications

American Board of Urology (2019)

Urology, Urology, American Board of (2009)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.7 out of 5

(77 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

34 Reviews

08/16/2024

Woods and his staff have always been great to work with

08/06/2024

He knows what he is doing

07/12/2024

It was a great experience

07/02/2024

Me gusta mucho el servicio y la coordinación del mismo

05/31/2024

Excellent

05/06/2024

Muy profesionales todos

04/12/2024

I trusted him during our visit.

04/12/2024

Dr Woods was excellent

03/19/2024

It has been a great experience really

03/01/2024

seems very knowledgeable

02/09/2024

It was above my expectations, it was fantastic

01/26/2024

He cares

12/15/2023

Keep up the good work.

12/08/2023

Muy bueno estoy muy satisfecho

11/23/2023

I like the professionalism and short waiting time.

11/19/2023

I feel very confident in his skill as a doctor.

11/17/2023

Pues todo grasias a dios salio muy bien

11/17/2023

Everything went well

11/12/2023

Everybody did a great job in all areas.

10/29/2023

Dr. Michael Woods is great

10/27/2023

Everything does very well from walking in the door to end of the procedure. Thank you!

09/29/2023

Not returning phone call or the numbers they gave would would just ring and ring with no one answering very upsetting

09/25/2023

Truthfully, my wife and I are very pleased with the care and concern offered in the past few weeks from all the staff we have met.

08/19/2023

All went well everyone very nice and efficient

08/16/2023

Great Doctor and all his support staff.

08/01/2023

Disappointed that dr. Was rushed and distracted.

07/30/2023

Overall xcellence

07/14/2023

Atento y paciente pues no habló mucho Inglés y me explico muy bien para poder entenderlo

07/14/2023

An Excellent experience

06/30/2023

The nuclear department where I was had been badly backed up. Hence, it was especially hurried. I addition, the lateness made my appointment cover the lunch hour.

06/29/2023

Overall very good experience

06/21/2023

Doctor wood is very caring and knowledgeable

03/21/2023

Everyone treats you good

01/17/2023

.
Show more

Publications

  • Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumors. Ellis, J. L.; Sontag-Milobsky, I.; Chen, V. S.; Rac, G.; Hartman, N. C.; Gorbonos, A.; Woods, M. E.; Flanigan, R. C.; Quek, M.; Patel, H. D.; Gupta, G. N.; Urologic oncology
  • Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. Apolo, A. B.; Ballman, K. V.; Sonpavde, G.; Berg, S.; Kim, W. Y.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D. M.; Grivas, P.; Chatta, G.; Reichert, Z. R.; Kim, J. W.; Bilen, M. A.; McGregor, B.; Singh, P.; Tripathi, A.; Cole, S.; Simon, N.; Niglio, S.; Ley, L.; Cordes, L.; Srinivas, S.; Huang, J.; Odegaard, M.; Watt, C.; Petrylak, D.; Hoffman-Censits, J.; Wen, Y.; Hahn, O.; Mitchell, C.; Tan, A.; Streicher, H.; Sharon, E.; Moon, H.; Woods, M.; Halabi, S.; Perez Burbano, G.; Morris, M. J.; Rosenberg, J. E.; The New England journal of medicine
  • MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer. Marras, M.; Ellis, J. L.; Copelan, O.; Naha, U.; Han, T.; Rac, G.; Quek, M. L.; Gorbonos, A.; Woods, M. E.; Flanigan, R. C.; Gupta, G. N.; Patel, H. D.; Urologic oncology
  • Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. Narayan, V. M.; Boorjian, S. A.; Alemozaffar, M.; Konety, B. R.; Shore, N. D.; Gomella, L. G.; Kamat, A. M.; Bivalacqua, T. J.; Montgomery, J. S.; Lerner, S. P.; Busby, J. E.; Poch, M.; Crispen, P. L.; Steinberg, G. D.; Schuckman, A. K.; Downs, T. M.; Mashni, J.; Lane, B. R.; Guzzo, T. J.; Bratslavsky, G.; Karsh, L. I.; Woods, M. E.; Brown, G.; Canter, D.; Luchey, A.; Lotan, Y.; Inman, B. A.; Williams, M. B.; Cookson, M. S.; Chang, S. S.; Sankin, A. I.; O'Donnell, M. A.; Sawutz, D.; Philipson, R.; Parker, N. R.; Yla-Herttuala, S.; Rehm, D.; Jakobsen, J. S.; Juul, K.; Dinney, C. P. N.; The Journal of urology
  • Robotic versus open radical cystectomy for bladder cancer: evaluation of complications, survival, and opioid prescribing patterns. Yang, R.; Rac, G.; Felice, M. D.; Pahouja, G.; Ko, C.; Okabe, Y.; Naha, U.; Chen, V. S.; Druck, A.; Gupta, G. N.; Woods, M. E.; Gorbonos, A.; Quek, M. L.; Patel, H. D.; Journal of robotic surgery
  • Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting Utilization. Patel, H. D.; Naha, U.; Chen, V. S.; Ko, C.; Yang, R.; Druck, A.; Rac, G.; Ellis, J. L.; Gupta, G. N.; Woods, M. E.; Gorbonos, A.; Flanigan, R.; Quek, M. L.; Urology practice
  • Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study. Pohar, K. S.; Patel, S.; Lotan, Y.; Trabulsi, E.; Woods, M.; Downs, T.; Huang, W. C.; Jones, J.; Taylor, J.; O'Donnell, M.; Bivalacqua, T. J.; DeCastro, J.; Steinberg, G.; Kamat, A. M.; Resnick, M. J.; Konety, B.; Schoenberg, M.; Jones, J. S.; Daneshmand, S.; Flexible Blue Light Study Group Collaborators; Urologic oncology
  • Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stage. Patel, H. D.; Man, A.; Koehne, E. L.; Rac, G.; Aragao, A. P.; Flanigan, R. C.; Gorbonos, A.; Gupta, G. N.; Woods, M. E.; Picken, M. M.; Quek, M. L.; Urologic oncology
  • Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Rose, T. L.; Weir, W. H.; Mayhew, G. M.; Shibata, Y.; Eulitt, P.; Uronis, J. M.; Zhou, M.; Nielsen, M.; Smith, A. B.; Woods, M.; Hayward, M. C.; Salazar, A. H.; Milowsky, M. I.; Wobker, S. E.; McGinty, K.; Millburn, M. V.; Eisner, J. R.; Kim, W. Y.; British journal of cancer
  • Reply by Authors. Matin, S. F.; Pierorazio, P. M.; Kleinmann, N.; Gore, J. L.; Shabsigh, A.; Hu, B.; Chamie, K.; Godoy, G.; Hubosky, S. G.; Rivera, M.; O'Donnell, M.; Quek, M.; Raman, J. D.; Knoedler, J. J.; Scherr, D.; Weight, C.; Weizer, A.; Woods, M.; Kaimakliotis, H.; Smith, A. B.; Linehan, J.; Coleman, J.; Humphreys, M. R.; Pak, R.; Lifshitz, D.; Verni, M.; Klein, I.; Konorty, M.; Strauss-Ayali, D.; Hakim, G.; Seltzer, E.; Schoenberg, M.; Lerner, S. P.; The Journal of urology
  • Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. Mitra, A. P.; Narayan, V. M.; Mokkapati, S.; Miest, T.; Boorjian, S. A.; Alemozaffar, M.; Konety, B. R.; Shore, N. D.; Gomella, L. G.; Kamat, A. M.; Bivalacqua, T. J.; Montgomery, J. S.; Lerner, S. P.; Busby, J. E.; Poch, M.; Crispen, P. L.; Steinberg, G. D.; Schuckman, A. K.; Downs, T. M.; Svatek, R. S.; Mashni, J.; Lane, B. R.; Guzzo, T. J.; Bratslavsky, G.; Karsh, L. I.; Woods, M. E.; Brown, G. A.; Canter, D.; Luchey, A.; Lotan, Y.; Krupski, T.; Inman, B. A.; Williams, M. B.; Cookson, M. S.; Keegan, K. A.; Andriole, G. L.; Sankin, A. I.; Boyd, A.; O'Donnell, M. A.; Philipson, R.; Ylä-Herttuala, S.; Sawutz, D.; Parker, N. R.; McConkey, D. J.; Dinney, C. P. N.; European urology
  • Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. Matin, S. F.; Pierorazio, P. M.; Kleinmann, N.; Gore, J. L.; Shabsigh, A.; Hu, B.; Chamie, K.; Godoy, G.; Hubosky, S. G.; Rivera, M.; O'Donnell, M.; Quek, M.; Raman, J. D.; Knoedler, J. J.; Scherr, D.; Weight, C.; Weizer, A.; Woods, M.; Kaimakliotis, H.; Smith, A. B.; Linehan, J.; Coleman, J.; Humphreys, M. R.; Pak, R.; Lifshitz, D.; Verni, M.; Klein, I.; Konorty, M.; Strauss-Ayali, D.; Hakim, G.; Seltzer, E.; Schoenberg, M.; Lerner, S. P.; The Journal of urology
  • Editorial Commentary. Woods, M. E.; Urology practice
  • Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. Rose, T. L.; Harrison, M. R.; Deal, A. M.; Ramalingam, S.; Whang, Y. E.; Brower, B.; Dunn, M.; Osterman, C. K.; Heiling, H. M.; Bjurlin, M. A.; Smith, A. B.; Nielsen, M. E.; Tan, H. J.; Wallen, E.; Woods, M. E.; George, D.; Zhang, T.; Drier, A.; Kim, W. Y.; Milowsky, M. I.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Rose, T. L.; Weir, W. H.; Mayhew, G. M.; Shibata, Y.; Eulitt, P.; Uronis, J. M.; Zhou, M.; Nielsen, M.; Smith, A. B.; Woods, M.; Hayward, M. C.; Salazar, A. H.; Milowsky, M. I.; Wobker, S. E.; McGinty, K.; Millburn, M. V.; Eisner, J. R.; Kim, W. Y.; British journal of cancer
  • Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-Prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. Harmon, G.; Chan, D.; Lee, B.; Miller, C.; Gorbonos, A.; Gupta, G.; Quek, M.; Woods, M.; Savir-Baruch, B.; Harkenrider, M. M.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study. Abdul-Muhsin, H.; Rocco, N.; Navaratnam, A.; Woods, M.; L'Esperance, J.; Castle, E.; Stroup, S.; World journal of urology
  • Management Trends in Pediatric Nonseminomatous Germ Cell Tumors. Koehne, E. L.; Patel, P. M.; Patel, H. D.; Srivastava, A.; Slovacek, H.; Gupta, G. N.; Woods, M. E.; Bowen, D. K.; Urology
  • Renal Cell Carcinoma with Direct Extension into the Gonadal Vein, Uterus, Fallopian Tube, and Bilateral Ovaries: A Case Report. Sweigert, S. E.; Bajic, P.; Aragao, A.; Picken, M.; Woods, M. E.; Journal of kidney cancer and VHL
  • Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Kleinmann, N.; Matin, S. F.; Pierorazio, P. M.; Gore, J. L.; Shabsigh, A.; Hu, B.; Chamie, K.; Godoy, G.; Hubosky, S.; Rivera, M.; O'Donnell, M.; Quek, M.; Raman, J. D.; Knoedler, J. J.; Scherr, D.; Stern, J.; Weight, C.; Weizer, A.; Woods, M.; Kaimakliotis, H.; Smith, A. B.; Linehan, J.; Coleman, J.; Humphreys, M. R.; Pak, R.; Lifshitz, D.; Verni, M.; Adibi, M.; Amin, M. B.; Seltzer, E.; Klein, I.; Konorty, M.; Strauss-Ayali, D.; Hakim, G.; Schoenberg, M.; Lerner, S. P.; The Lancet. Oncology
  • Optimal Cystectomy Outcome: A Composite Measurement Evaluating Quality of Care and Mortality Benefit. Patel, P. M.; Doshi, C. P.; Belshoff, A.; Nelson, M.; Sweigert, P. J.; Bunn, C.; Kulshrestha, S.; Baker, M.; Woods, M.; Gupta, G. N.; Urology
  • Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC). Eulitt, P. J.; Altun, E.; Sheikh, A.; Wong, T. Z.; Woods, M. E.; Rose, T. L.; Wallen, E. M.; Pruthi, R. S.; Smith, A. B.; Nielsen, M. E.; Whang, Y. E.; Kim, W. Y.; Godley, P. A.; Basch, E. M.; David, G. U.; Ramirez, J.; Deal, A. M.; Rathmell, W. K.; Chen, R. C.; Bjurlin, M. A.; Lin, W.; Lee, J. K.; Milowsky, M. I.; Clinical genitourinary cancer
  • Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018. Lotan, Y.; Bivalacqua, T. J.; Downs, T.; Huang, W.; Jones, J.; Kamat, A. M.; Konety, B.; Malmström, P. U.; McKiernan, J.; O'Donnell, M.; Patel, S.; Pohar, K.; Resnick, M.; Sankin, A.; Smith, A.; Steinberg, G.; Trabulsi, E.; Woods, M.; Daneshmand, S.; Nature reviews. Urology
  • Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Ahmed, K.; Khan, S. A.; Hayn, M. H.; Agarwal, P. K.; Badani, K. K.; Balbay, M. D.; Castle, E. P.; Dasgupta, P.; Ghavamian, R.; Guru, K. A.; Hemal, A. K.; Hollenbeck, B. K.; Kibel, A. S.; Menon, M.; Mottrie, A.; Nepple, K.; Pattaras, J. G.; Peabody, J. O.; Poulakis, V.; Pruthi, R. S.; Redorta, J. P.; Rha, K. H.; Richstone, L.; Saar, M.; Scherr, D. S.; Siemer, S.; Stoeckle, M.; Wallen, E. M.; Weizer, A. Z.; Wiklund, P.; Wilson, T.; Woods, M.; Khan, M. S.; European urology
  • Multicenter experience with robot-assisted radical prostatectomy in renal transplant recipients. Polcari, A. J.; Allen, J. C.; Nunez-Nateras, R.; Mmeje, C. O.; Andrews, P. E.; Milner, J. E.; Castle, E. P.; Woods, M. E.; Urology
  • Effect of the phosphodiesterase-5 inhibitor zaprinast on ischemia-reperfusion injury in rats. Polcari, A. J.; Farooq, A. V.; Woods, M. E.; Ripsch, M. S.; Picken, M.; Turk, T. M.; White, F. A.; Journal of endourology
  • Right renal vein aneurysm discovered incidentally during laparoscopic nephrectomy. Rao, M. V.; Polcari, A. J.; Sundaram, V.; Foster, R. M.; Hershberger, R. C.; Woods, M.; Urology
  • Robot-assisted radical cystectomy: recent advances and review of the literature. Woods, M. E.; Wiklund, P.; Castle, E. P.; Current opinion in urology
  • Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. Polcari, A. J.; Hugen, C. M.; Sivarajan, G.; Woods, M. E.; Paner, G. P.; Flanigan, R. C.; Quek, M. L.; Journal of endourology